1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
  1. Shampoo
    A recent Scientific American article highlighted the relationship between nicotonic receptors and schizophrenia with interesting potential for future studies as well as those under way. Here is the abridged online version...

    "Scientific American Mind - December, 2007

    Smoking Away Schizophrenia?

    Nicotinelike drugs show promise for alleviating cognitive impairment
    By Lisa Conti

    Schizophrenia is famous for its symptoms of hallucinations and delusions, but sufferers also face debilitating cognitive impairment—and standard treatments with antipsychotic medications do little to compensate for intellectual loss. Seeking improved mental clarity, many patients turn to a seemingly mundane source: cigarettes. The extraordinarily high incidence of smoking in individuals with schizophrenia—about 85 percent of patients smoke compared with some 20 percent of the general population—has spurred researchers to investigate the therapeutic effects of nicotine in the diseased brain.

    Every schizophrenia patient suffers some degree of deficit in memory, attention and thought organization, but no medication currently exists to treat these cognitive impairments. According to patients who smoke, cigarettes alleviate some of these symptoms, but research has found that the effect is short-lived and detrimental to overall health. The receptors to which nicotine binds in the brain quickly become desensitized, rendering smoking ultimately ineffective. And while the positive effects are disappearing, addiction is under way.

    As an alternative, researchers are investigating newly derived chemical compounds that bind weakly to the brain’s nicotine receptors. Many of these binding agents are being tested in people who have schizophrenia, Alzheimer’s disease or attention-deficit hyperactivity disorder (ADHD). Although the mechanisms underlying nicotine’s cognitive effects remain unclear, scientists think it might improve focus by enhancing the brain’s ability to filter out unwanted external stimuli. Schizophrenia alters the chemical communication signals used by neurons, making it difficult for the brain to isolate a single process and devote conscious attention to it. Nicotine modifies these signaling processes and may help dampen extraneous neuronal activity.

    Schizophrenia expert Carol Tamminga, professor of psychiatry at the University of Texas Southwestern Medical School, says, “Doctors like me hope that in five or 10 years we’ll have medications for different symptom domains. It’s unclear if we’re going to get medications that target specific aspects of cognition, like an attention or memory enhancer specifically, or if we’re going to get drugs that cross the board in a more global way.” But for patients, any treatment would be a welcome relief."


To make a comment simply sign up and become a member!